| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VTGN | VistaGen Therapeutics, Inc. | Smith Mark Alan | CHIEF MEDICAL OFFICER | Jun 30, 2022 | Option Exercise | $0.75 | 5,000 | 3,740 | 19,915 | Jul 15, 2022, 04:30 PM | |
| VTGN | VistaGen Therapeutics, Inc. | Smith Mark Alan | CHIEF MEDICAL OFFICER | Dec 31, 2021 | Option Exercise | $1.66 | 2,655 | 4,401 | 14,915 | Jan 03, 2022, 04:25 PM | |
| VTGN | VistaGen Therapeutics, Inc. | Smith Mark Alan | CHIEF MEDICAL OFFICER | Jun 30, 2021 | Option Exercise | $1.95 | 2,260 | 4,399 | 12,260 | Jul 02, 2021, 04:11 PM | |
| VTGN | VistaGen Therapeutics, Inc. | Smith Mark Alan | CHIEF MEDICAL OFFICER | Dec 31, 2020 | Option Exercise | $0.45 | 5,000 | 2,261 | 10,000 | Jan 04, 2021, 04:55 PM | |
| VTGN | VistaGen Therapeutics, Inc. | Smith Mark Alan | CHIEF MEDICAL OFFICER | Jun 30, 2020 | Option Exercise | $0.45 | 5,000 | 2,240 | 5,000 | Jul 01, 2020, 05:33 PM |
Menu